Watch this on-demand webinar held on August 25, 2022, to learn more about the challenges for developing clinically relevant preclinical models for brain cancer.
In this webinar, Dr. Nagendra Ningaraj, Global Senior Director of Scientific Affairs, Aragen Life Sciences will highlight on:
Challenges of clinically relevant preclinical brain metastasis models
Role of blood-brain barrier (BBB) in anticancer drug delivery
Aggressive metastases in the central nervous system (CNS) and the effectiveness of current therapies
Progress in developing specific models to study metastatic cancers like triple-negative breast cancer, melanomas and lung cancer
How optimizing these models should improve the clinical impact by understanding the biology of aggressive metastatic tumors in patients
Selection of metastatic brain cells in murine models
About genetically engineered mouse models
Dr. Nagendra Ningaraj
Global Sr. Director of Scientific Affairs, Aragen Life Sciences
Challenges of clinically relevant preclinical brain metastasis models
Role of blood-brain barrier (BBB) in anticancer drug delivery
Aggressive metastases in the central nervous system (CNS) and the effectiveness of current therapies
Progress in developing specific models to study metastatic cancers like triple-negative breast cancer, melanomas and lung cancer
How optimizing these models should improve the clinical impact by understanding the biology of aggressive metastatic tumors in patients
Selection of metastatic brain cells in murine models
About genetically engineered mouse models
Dr. Nagendra Ningaraj
Global Sr. Director of Scientific Affairs, Aragen Life Sciences
